BioDlink Commends Junshi Biosciences as its Bispecific ADC Candidate JS212 Receives IND Approval

September 12, 2025

BioDlink, a leading global CDMO, extends its congratulations to Junshi Biosciences, on receiving Investigational New Drug (IND) approval

Share the Post:

Related Posts

How Much Time Off Should You Take From Throwing After the Baseball Season

We discuss what the science shows about how much time off baseball pitchers should take from throwing in the offseason.

Massage Therapy for Arthritis Pain Relief: A Guide

Massage Therapy for Arthritis: Evidence-Based Benefits, Techniques, and What to Expect Massage therapy for arthritis offers meaningful relief from the

We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.

Accept